about
Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group.Thrombosis as a complication of central venous access in pediatric patients with malignancies: a 5-year single-center experience.Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapyMB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-propertiesEfforts of the human immune system to maintain the peripheral CD8+ T cell compartment after childhood thymectomySrc-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor-induced interleukin 12 synthesis.Stem cells, melanoma and cancer stem cells: the good, the bad and the evil?Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.Indication for allogeneic stem cell transplantation in Glanzmann's thrombasthenia.Dendritic cell vaccination in pediatric gliomas: lessons learnt and future perspectives.Tumor antigen-specific T cells for immune monitoring of dendritic cell-treated glioblastoma patients.Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients.Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killingCancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiationTGFβ and IL10 have an impact on risk group and prognosis in childhood ALL.Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells.Stimulating surface molecules, Th1-polarizing cytokines, proven trafficking--a new protocol for the generation of clinical-grade dendritic cells.Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies.Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.Age-related changes in intracellular cytokine expression in healthy children.Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database.Dasatinib medication causing profound immunosuppression in a patient after haploidentical SCT: functional assays from whole blood as diagnostic clues.Human and Murine Innate Immune Cell Populations Display Common and Distinct Response Patterns during Their In Vitro Interaction with the Pathogenic Mold Aspergillus fumigatus.Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation.CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation.Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report.Successful treatment of an infant with CDA type II by intrauterine transfusions and postnatal stem cell transplantation.Formula-feeding is associated with shift towards Th1 cytokines.Impaired B-cell reconstitution in children after chemotherapy for standard or medium risk acute precursor B-lymphoblastic leukemia.Pre-differentiated human committed T-lymphoid progenitors promote peripheral T-cell re-constitution after stem cell transplantation in immunodeficient mice.A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.AbstractsEarly and late complications following hematopoietic stem cell transplantation in pediatric patients - A retrospective analysis over 11 yearsOnset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in childrenExperiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemiaOKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplantsA prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors
P50
Q31115048-4CAED506-19EC-41F2-ABA5-AC8F7F7B5458Q34333047-5C1FEEA8-A2EE-48EF-9C65-CEFD1758862AQ34594769-63E54E79-2413-45C8-AA86-B4A9B84F6186Q35925281-7361CAE2-9848-40D0-84E1-C76524964D41Q36530581-F25CA008-C465-456C-A71A-3D244B7CA789Q37098840-3FACC2A2-A142-4220-9E7F-8E01D72E628BQ37352619-9AC4C3A4-4CA1-4B77-BAFE-6852E90DE1DDQ37581839-F72BFD7E-E561-4AA2-B4EB-CA819E07AB7AQ38122656-4460D044-22B0-45D8-90DD-17508E964DF2Q38176625-446C071A-374E-4F4A-ACC5-25DF1EC409AAQ39594627-0A7567E8-900F-40B2-B4E4-2C21FFBCE8E2Q39932916-791039AD-C849-41F7-8DAD-8C6BFFE595AFQ39953895-CDBEAF5A-E9CE-4DA8-A01E-862A95DE9C4CQ40070259-DA27FC1D-DD80-4814-8955-6E463204B9E4Q40454427-32C367B7-CC80-476C-8293-28638F665A90Q40987686-C2CB57A5-B263-4AD2-949A-1AA82AC1C7C6Q41591704-A627DED5-9177-4384-9123-8CB608550BDFQ41724050-EBC62592-8FAF-41B6-98F6-B39351DDA7A2Q42218510-948BD37F-7174-4486-A298-FF75C7C08314Q42271588-13DD81DB-6BFD-443E-9323-5B6F66CE79E0Q43065873-EDEDB224-B581-4E68-A965-2FCE8490E7EBQ44383245-046FC6EC-BE8B-4728-8278-EA5E6DB4F12AQ45961057-73DDF7F8-1D50-4172-86C7-89AA7B042D40Q46219747-06760E4E-C1A3-4DDA-9DB4-288088745AE3Q46253684-3D54655A-16DB-4066-BB39-446B75F16AD1Q47099022-59497D99-B1A7-41EC-B223-70F6D6E7AA4AQ47861323-834C5B59-6DEE-4E2A-B735-2AC85B5C01EEQ48181290-2EAEDD7D-0144-43D0-8CF5-F8098EFEE544Q50057949-138EAA47-2315-43CB-A280-5AB990636A6DQ50484761-1B80CFEE-53D1-4303-8296-B625842E099FQ50854724-2D5CD003-D961-4807-9EE3-F0C8A5CFF9E6Q50891567-2FDACF83-D844-4D02-B6C9-5153A8B7108AQ51853658-B6837EE7-5A2B-4FEB-9A9E-C935B6AB3A0AQ52006361-569E4D11-25E9-43D4-B0D1-3726AE1A8E2BQ57199717-D9F13319-0E4A-4265-A3A1-52BD28E08F0BQ57459923-276D65B2-80E6-495E-AD23-99C48FB8D6FBQ60028877-947D8BAF-B966-4691-AFF6-6BA89D21E7C8Q63386812-0EDDB5FA-B073-45D0-A143-8EB2B082C1E5Q73309646-4A9DDE0B-E14D-405B-A87E-5D217938C883Q74445815-B25AD417-ED10-447D-99AA-61E4ABF390CD
P50
description
researcher ORCID ID = 0000-0002-8099-5903
@en
wetenschapper
@nl
name
Matthias Eyrich
@ast
Matthias Eyrich
@en
Matthias Eyrich
@es
Matthias Eyrich
@nl
type
label
Matthias Eyrich
@ast
Matthias Eyrich
@en
Matthias Eyrich
@es
Matthias Eyrich
@nl
prefLabel
Matthias Eyrich
@ast
Matthias Eyrich
@en
Matthias Eyrich
@es
Matthias Eyrich
@nl
P106
P21
P31
P496
0000-0002-8099-5903